<--GAT-->
Clinical Topics

Better Survival for NSCLC Patients Treated by Military Medicine

by U.S. Medicine

November 29, 2018

BETHESDA, MD—Does universal healthcare access provided by the MHS translate into improved patient outcomes for non-small cell lung cancer?

That was the question examined in a new study published in Cancer Epidemiology, Biomarkers & Prevention. Survival of NSCLC patients treated within the MHS was compared to the U.S. general population.1

The study was led by researchers from the John P. Murtha Cancer Center, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center. MHS data for the study were from the DoD’s Automated Central Tumor Registry (ACTUR), while data for the general population came from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program.

The focus was on NSCLC patients diagnosed between Jan. 1, 1987, and Dec. 31, 2012, in ACTUR and a sample of SEER patients who were matched to the ACTUR patients on age group, sex, race and year of diagnosis group with a matching ratio of 1:4. Follow-up continued through Dec. 31, 2013.

Ultimately, 16,257 NSCLC patients were identified from ACTUR ,and 65,028 matched patients from SEER.

Results indicated that, Compared with SEER patients, ACTUR patients had significantly better overall survival (log-rank P < 0.001). The better overall survival among the ACTUR patients remained after adjustment for potential confounders (HR = 0.78, 95% confidence interval, 0.76-0.81).

Researchers emphasized that the survival advantage of the ACTUR patients was present regardless of cancer stage, grade, age group, sex or race.

“The MHS’s universal care and lung cancer care programs may have translated into improved survival among NSCLC patients,” study authors concluded, pointing out that their results confirms that NSCLC patients with universal care access have better outcomes.

1. Lin J, Kamamia C, Brown D, Shao S, McGlynn KA, Nations JA, Carter CA, Shriver CD, Zhu K. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population. Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):673-679. doi: 10.1158/1055-9965.EPI-17-0822.



Related Articles

VA Overall Appointment Wait Times Shorter than the Private-Sector

Despite intense scrutiny of wait times for veterans seeking VA care over the last three years, a new study pointed out that delays in the private sector weren’t statistically less in 2014 and that, possibly because of the focus, wait times now are significantly shorter for the VA compared to private-sector healthcare facilities.

Senate Blocks Agent Orange Exposure Extension to Blue Water Veterans

Blue Water Navy veterans who claim to be impacted by toxic exposure while serving off the coast of Vietnam were forced to grapple with disappointment once again as the 115th Congress ended without passing legislation addressing their VA benefits.


U.S. Medicine Recommends


More From oncology

Oncology

Hypertension, MGUS Associated with Herbicide Exposure in Vietnam Veterans

Based on a new review, two conditions–one extremely common and the other rare–appear to be related to herbicide exposure during the Vietnam War era.

Oncology

Detailed Medical History Crucial for Lung Disease Diagnosis

Both general medicine physicians and specialists can find interstitial lung disease (ILD) and pulmonary fibrosis confusing, according to a recent study.

Oncology

Melanomas Associated With Internal Malignancy Risk

Genetic and environmental risk factors have been associated with the development of multiple primary melanomas (MPM) but a new study questioned whether those patients might have increased predisposition to developing internal malignancies.

Oncology

Some RCC Risk Factors Can Be Modified

Obesity, hypertension and smoking are the three modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma, according to a new study.

Oncology

Veterans Study Calls for Better Guidance on Lung Cancer Treatment

With increased imaging now detecting lung cancer nodules in sicker patients, a new report suggested that guidelines should be more directive in how to maximize benefit and minimize harm, while taking into account comorbidities and life expectancy.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up